Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG ... enhance procedural efficiency and improve patient outcomes for interventional procedures – bringing better care to more people.

Nick shares his insights on the pressing challenges facing the U.S. healthcare market and how Philips is transforming patient care through advanced data analytics, diagnostics, and remote monitoring.

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

It also showcases how this innovative new technology, which resulted from Philips’ powerful in-house development capabilities, can ease the patient experience by streamlining complex ...

November 12, 2024Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Philips' patient- and people-centric innovation leverages advanced ... ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease GlobeNewswire November 04, 2024 With a unique world-first ability to ...